Arrowhead Pharmaceuticals, Inc. (ARWR)
$60.73-3.22%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8.6B
- Beta
- 1.30
- P/E (TTM)
- -27.47
- Short % float
- 8.76%
- Days to cover
- 4.0
- SI change
- +16.1%
- 1W
- -2.60%
- 1M
- -26.70%
- vs SPY 1W
- -3.02%
- vs SPY 1M
- -28.76%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on ARWR?
- LOPJLB’s latest quantitative signal on Arrowhead Pharmaceuticals, Inc. (ARWR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ARWR in?
- Arrowhead Pharmaceuticals, Inc. (ARWR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Arrowhead Pharmaceuticals, Inc. (ARWR) do?
- Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AA…